Twist Bioscience Corporation TWST
103.32 USD -8.30 (-7.44%)
Regular-session close
105.01 +1.69 +1.64%
After hours · Nov 20, 7:50 PM ET
101.00 Day range 108.50
26.07 52-week range 205.00
- YTD
- +225.73%
- 1 year
- +296.32%
News
seekingalpha.com Artisan Global Discovery Fund Q3 2026 Portfolio Activity During the quarter, we initiated new positions in Manhattan Associates, Okta and Clean Harbors. In addition to Twilio, West Pharmaceutical and RBC Bearings, we added to Neptune Insurance, Lattice…
seekingalpha.com Twist Bioscience: Long-Term 'Buy' On AI Discovery For Biotech I believe TWST can, over time, capture more of a customer's R&D budget if initial DNA orders lead to more repeat testing and lab data work. TWST's AI drug discovery is at the heart of my growth bull…benzinga.com Barclays Maintains Overweight on Twist Bioscience, Lowers Price Target to $130 Barclays analyst Luke Sergott maintains Twist Bioscience (NASDAQ:TWST) with a Overweight and lowers the price target from $215 to $130.
benzinga.com CrowdStrike To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Friday Analysts raised CrowdStrike and Jazz targets, while cutting targets for Cisco, Fermi, Twist Bioscience, Applied Materials, Firefly and Nebius.benzinga.com Leerink Partners Maintains Outperform on Twist Bioscience, Lowers Price Target to $175 Leerink Partners analyst Puneet Souda maintains Twist Bioscience (NASDAQ:TWST) with a Outperform and lowers the price target from $190 to $175.
benzinga.com TD Cowen Maintains Buy on Twist Bioscience, Lowers Price Target to $137 TD Cowen analyst Brendan Smith maintains Twist Bioscience (NASDAQ:TWST) with a Buy and lowers the price target from $190 to $137.
benzinga.com Canaccord Genuity Maintains Buy on Twist Bioscience, Lowers Price Target to $150 Canaccord Genuity analyst Kyle Mikson maintains Twist Bioscience (NASDAQ:TWST) with a Buy and lowers the price target from $205 to $150.
benzinga.com Baird Maintains Outperform on Twist Bioscience, Lowers Price Target to $135 Baird analyst Catherine Ramsey maintains Twist Bioscience (NASDAQ:TWST) with a Outperform and lowers the price target from $187 to $135.
benzinga.com Twist Bioscience 2027 Outlook Signals Sharp Slowdown in AI Drug Discovery Growth Twist Bioscience (TWST) shares fell Thursday after a 2027 outlook signaled slower AI drug discovery growth, overshadowing a strong Q4 beat.
benzinga.com Twist Bioscience Q4 2026 Earnings Call Transcript Twist Bioscience (NASDAQ:TWST) reported fourth-quarter financial results on Thursday. The transcript from the company’s fourth-quarter earnings call has been provided below.This transcript is brought…benzinga.com Twist Bioscience Q4 EPS $(0.32) Beats $(0.34) Estimate, Sales $126.644M Beat $123.085M Estimate Twist Bioscience (NASDAQ:TWST) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.34) by 5.88 percent. This is a 28.89 percent increase over losses of…
benzinga.com Twist Bioscience Sees FY2027 Sales $550.000M-$560.000M vs $547.137M Est Twist Bioscience (NASDAQ:TWST) sees FY2027 sales of $550.000 million-$560.000 million vs $547.137 million analyst estimate.
benzinga.com Twist Bioscience Sees Q1 Sales $130.000M-$132.000M vs $126.354M Est Twist Bioscience (NASDAQ:TWST) sees Q1 sales of $130.000 million-$132.000 million vs $126.354 million analyst estimate.
benzinga.com Cisco Systems, Applied Materials On Deck Thursday As AI Demand Faces Test Cisco Systems and Applied Materials headline Thursday’s reports, with investors looking for evidence that AI infrastructure demand can keep supporting semiconductor and networking growth. Brookfield,…
benzinga.com Twist Bioscience Stock Sinks as Bear Cave Raises Valuation Concerns Twist Bioscience Corp (NASDAQ:TWST) shares are plunging Thursday. The Bear Cave, which Hunterbrook Media owns, said that the life science tools company's stock price may have run ahead of its…benzinga.com Twist Bioscience Proposes Derivative Litigation Settlement Featuring Corporate Governance Reforms And $1M In Legal Fees SUMMARY NOTICE OF PROPOSED SETTLEMENT OF DERIVATIVE ACTIONTO: ALL CURRENT RECORD HOLDERS AND BENEFICIAL OWNERS OF TWIST BIOSCIENCE CORPORATION ("TWIST" OR THE "COMPANY") COMMON STOCK AS OF OCTOBER 15,
benzinga.com 10 Health Care Stocks Whale Activity In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
